Evidence map›Paper›PMID 28605543›Full record

ArticlePathogens and disease2017

Dual action of bacteriocin PLNC8 αβ through inhibition of Porphyromonas gingivalis infection and promotion of cell proliferation.

Torbjörn Bengtsson, Boxi Zhang, Robert Selegård, Emanuel Wiman, Daniel Aili, Hazem Khalaf

Open access · hybridAbstract read
In one paragraph

Article in Pathogens and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Antibacterial Effects of Bacteriocin PLNC8 againstFoods (Basel, Switzerland) · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Torbjörn BengtssonSchool of Medical Sciences, Örebro University, 70182 Örebro, Sweden.
Boxi ZhangDepartment of Physiology and Pharmacology, Karolinska Institutet, 17177 Stockholm, Sweden.
Robert SelegårdSchool of Medical Sciences, Örebro University, 70182 Örebro, Sweden.
Emanuel WimanSchool of Medical Sciences, Örebro University, 70182 Örebro, Sweden.
Daniel AiliDivision of Molecular Physics, Department of Physics, Chemistry and Biology (IFM), Linköping University, 581 83 Linköping, Sweden.
Hazem KhalafSchool of Medical Sciences, Örebro University, 70182 Örebro, Sweden.
Örebro University · SELinköping University · SEKarolinska Institutet · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periodontitis is a chronic inflammatory disease that is characterised by accumulation of pathogenic bacteria, including Porphyromonas gingivalis, in periodontal pockets. The lack of effective treatments has emphasised in an intense search for alternative methods to prevent bacterial colonisation and disease progression. Bacteriocins are bacterially produced antimicrobial peptides gaining increased consideration as alternatives to traditional antibiotics. We show rapid permeabilisation and aggregation of P. gingivalis by the two-peptide bacteriocin PLNC8 αβ. In a cell culture model, P. gingivalis was cytotoxic against gingival fibroblasts. The proteome profile of fibroblasts is severely affected by P. gingivalis, including induction of the ubiquitin-proteasome pathway. PLNC8 αβ enhanced the expression of growth factors and promoted cell proliferation, and suppressed proteins associated with apoptosis. PLNC8 αβ efficiently counteracted P. gingivalis-mediated cytotoxicity, increased expression of a large number of proteins and restored the levels of inflammatory mediators. In conclusion, we show that bacteriocin PLNC8 αβ displays dual effects by acting as a potent antimicrobial agent killing P. gingivalis and as a stimulatory factor promoting cell proliferation. We suggest preventive and therapeutical applications of PLNC8 αβ in periodontitis to supplement the host immune defence against P. gingivalis infection and support wound healing processes.

Indexed as

Anti-Bacterial AgentsApoptosisBacteriocinsCell Membrane PermeabilityCell ProliferationFibroblastsGene Expression RegulationGene OntologyGingivaHost-Pathogen InteractionsHumansIntercellular Signaling Peptides and ProteinsMolecular Sequence AnnotationPorphyromonas gingivalisPrimary Cell CultureProteasome Endopeptidase ComplexAnti-Bacterial AgentsBacteriocinsIntercellular Signaling Peptides and ProteinsProteasome Endopeptidase ComplexProteomeUbiquitinbacteriocincell proliferationperiodontitisPLNC8Porphyromonas gingivalisproteomics

Identifiers

PMID28605543
PMCPMC5808647
OpenAlexW2626968621

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.